Nascent Pharma Holdings, Inc. (NASC)
OTCMKTS · Delayed Price · Currency is USD
0.0245
+0.0015 (6.52%)
At close: Sep 17, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Hemp Derived Products
1.34M
Log In
Log In
Log In
Log In
Upgrade
Hemp Derived Products Growth
-75.81%
Log In
Log In
Log In
Log In
Upgrade
Services
819.63K
Log In
Log In
Log In
Log In
Upgrade
Services Growth
-29.43%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
2.16M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-67.76%
Log In
Log In
Log In
Log In
Upgrade